Is intestinal microbiota critically involved in metabolic inflammation?
Join us in Innsbruck, Austria, February 26-28, 2015
to find out.
With only 3 weeks until the EASL Microbiota, Metabolism and NAFLD conference begins it’s time to register
to secure your seat.
NAFLD has evolved over recent years as the most common liver disease worldwide paralleled by the obesity pandemic. Metabolic and inflammatory aspects have been increasingly recognized to play a crucial role in obesity and related disorders including NAFLD.
At the EASL Monothematic Conference we will discuss the key role of metabolic and immune processes as driving forces in these diseases.